Carl Zeiss Meditec AG

XTRA:AFX Stok Raporu

Piyasa değeri: €4.0b

Carl Zeiss Meditec Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Carl Zeiss Meditec kazanç ve gelirin sırasıyla yıllık 20.7% ve 6.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 20.6% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 11.6% olacağı tahmin edilmektedir.

Anahtar bilgiler

20.7%

Kazanç büyüme oranı

20.61%

EPS büyüme oranı

Medical Equipment kazanç büyümesi12.8%
Gelir büyüme oranı6.8%
Gelecekteki özkaynak getirisi11.64%
Analist kapsamı

Good

Son güncelleme30 Jul 2025

Gelecekteki son büyüme güncellemeleri

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11
Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Carl Zeiss Meditec (ETR:AFX) Could Be Struggling To Allocate Capital

Jul 01
Carl Zeiss Meditec (ETR:AFX) Could Be Struggling To Allocate Capital

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 19
Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

May 16
Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?

Apr 28
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?

Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year

Mar 23
Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year

Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment

Mar 20
Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment

After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar

Mar 15
After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar

These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Mar 03
These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively

Feb 10
Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively

More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%

Jan 10
More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%

Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?

Dec 28
Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?
author-image

AI-Powered Innovations Like KINEVO 900 S And VISUMAX 800 Set To Drive Revenue Growth

New product pipeline and integration of DORC expected to drive revenue and enhance net margins with innovative AI medical solutions.

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Dec 04
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk

Nov 19
Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk

Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Sep 19
Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Sep 06
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

Aug 23
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Aug 09
At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jul 11
Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Jun 10
Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

May 26
Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11
Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

May 09
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Mar 24
Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Mar 11
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Feb 12
Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jan 29
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Dec 08
What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Nov 08
Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Oct 24
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Sep 24
Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Sep 08
Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jul 24
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Jun 19
We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Jun 06
Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

May 22
Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Apr 19
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Feb 26
Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 10
Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Jan 28
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Jan 12
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Dec 29
Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Dec 14
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Nov 04
What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Kazanç ve Gelir Büyüme Tahminleri

XTRA:AFX - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (EUR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
9/30/20272,54025025637212
9/30/20262,33820121933815
9/30/20252,20315514726315
3/31/20252,16915683196N/A
12/31/20242,082157N/AN/AN/A
9/30/20242,06617995247N/A
6/30/20242,066203N/AN/AN/A
3/31/20242,062261122263N/A
12/31/20232,094277N/AN/AN/A
9/30/20232,089290137251N/A
6/30/20232,080308N/AN/AN/A
3/31/20232,02227863162N/A
12/31/20221,963307N/AN/AN/A
9/30/20221,903294106188N/A
6/30/20221,781245N/AN/AN/A
3/31/20221,735264207285N/A
12/31/20211,688228N/AN/AN/A
9/30/20211,647236297363N/A
6/30/20211,566235N/AN/AN/A
3/31/20211,388159240290N/A
12/31/20201,335130N/AN/AN/A
9/30/20201,335122134179N/A
6/30/20201,400120N/AN/AN/A
3/31/20201,507166132171N/A
12/31/20191,505170N/AN/AN/A
9/30/20191,459160173220N/A
6/30/20191,382153N/AN/AN/A
3/31/20191,334129195242N/A
12/31/20181,310127N/AN/AN/A
9/30/20181,281126N/A187N/A
6/30/20181,251124N/AN/AN/A
3/31/20181,216129N/A56N/A
12/31/20171,205132N/AN/AN/A
9/30/20171,190134N/A38N/A
6/30/20171,154123N/AN/AN/A
3/31/20171,135112N/A85N/A
12/31/20161,106113N/AN/AN/A
9/30/20161,08898N/A112N/A
6/30/20161,09078N/A132N/A
3/31/20161,08380N/A96N/A
12/31/20151,06261N/A73N/A
9/30/20151,04062N/A57N/A
6/30/201598470N/A34N/A
3/31/201594666N/A44N/A
12/31/201493873N/A60N/A
9/30/201490975N/A63N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: AFX 'nin tahmini kazanç büyümesi (yıllık 20.7% ) tasarruf oranının ( 1.3% ) üzerindedir.

Kazançlar ve Piyasa: AFX şirketinin kazançlarının (yıllık 20.7% ) German pazarından (yıllık 16.7% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: AFX şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: AFX şirketinin gelirinin (yıllık 6.8% ) German pazarından (yıllık 6.1% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: AFX şirketinin gelirinin (yıllık 6.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: AFX 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 11.6 %).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2025/08/01 04:45
Gün Sonu Hisse Fiyatı2025/08/01 00:00
Kazançlar2025/03/31
Yıllık Kazançlar2024/09/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Carl Zeiss Meditec AG 32 Bu analistlerden 15, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Samuel EnglandBerenberg
Scott BardoBerenberg
Julien OuaddourBofA Global Research